Frequency of hereditary thrombophilia, anticoagulant activity, and homocysteine levels in patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 6, 2011, Pages 527-533

  Dogan, Ovgu Ozkan ^a   Simsek, Yavuz ^a   Celen, Sevki ^a   Danisman, Nuri ^a  

^a Dr Zekai Tahir Burak Training and Research Hospital   (Turkey)

Author keywords

Antithrombin III; Elevated liver functions and low thrombocyte count (HELLP) syndrome; Hemolysis; Protein C; Protein S; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; PROTEIN C; PROTEIN S;

ADULT; ANTICOAGULATION; ANTITHROMBIN III DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HELLP SYNDROME; HUMAN; STATISTICAL SIGNIFICANCE; THROMBOPHILIA;

ADOLESCENT; ADULT; ANTITHROMBIN III; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; FEMALE; HELLP SYNDROME; HOMOCYSTEINE; HUMANS; PREGNANCY; PROTEIN C; PROTEIN S; THROMBOPHILIA; TURKEY; YOUNG ADULT;

EID: 80052778009     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01397.x     Document Type: Article

References (32)

1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 15, 142: 159-167. (Pubitemid 12222094)
2. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53-56.
3. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995; 22: 781-791.
4. Heijboer H, Brandjes DP, Buller HR et al. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-1516.
5. Pabinger I. Hereditary deficiency of antithrombin III, PC and PS: Prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinolysis 1992; 3: 547-553.
6. Tranquilli AL, Giannubilo SR, Dell'uomo B, Grandone E. Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors. Eur J Obstet Gynecol Reprod Biol 2004; 1, 117: 144-147. (Pubitemid 39487321)
7. Nagy B, Varkonyi T, Molvarec A et al. Leptin gene (TTTC)(n) microsatellite polymorphism in pre-eclampsia and HELLP syndrome. Clin Chem Lab Med 2009; 47: 1033-1037.
8. Nagy B, Savli H, Molvarec A et al. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses. Clin Chim Acta 2008; 389: 126-131.
9. Molvarec A, Rigó J Jr, Bõze T et al. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thromb Haemost 2009; 101: 305-311.
10. Madách K, Molvarec A, Rigó J et al. Elevated serum 70 kDa heat shock protein level reflects tissue damage and disease severity in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Eur J Obstet Gynecol Reprod Biol 2008; 139: 133-138.
11. Molvarec A, Prohászka Z, Nagy B et al. Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. J Reprod Immunol 2007; 73: 172-179. (Pubitemid 46399953)
12. Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM. Maternal and fetal inherited thrombophilia are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185: 153-157. (Pubitemid 32681810)
13. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 1998; 179: 1359-1375. (Pubitemid 28533800)
14. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96: 45-49. (Pubitemid 30336278)
15. Brenner B, Hoffman R, Blumenfeld Z et al. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by Enoxaparin. Thromb Haemost 2000; 83: 693-697. (Pubitemid 30248516)
16. Yuan HT, Haig D, Ananth Karumanchi S. Angiogenic factors in the pathogenesis of preeclampsia. Curr Top Dev Biol 2005; 71: 297-312.
17. Lindoff C, Ingemarsson I, Martinsson G, Segelmark M, Thysell H, Astedt B. Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997; 176: 457-460. (Pubitemid 27107939)
18. Osmanaǧaoǧ lu MA, Topçuoǧ lu K, Ozeren M, Bozkaya H. Coagulation inhibitors in preeclamptic pregnant women. Arch Gynecol Obstet 2005; 271: 227-230. (Pubitemid 40562100)
19. Aznar J, Gilabert J, Estellés A, España F. Fibrinolytic activity and protein C in preeclampsia. Thromb Haemost 1986; 30, 55: 314-317. (Pubitemid 16074154)
20. Weenink GH, Treffers PE, Vijn P, Smorenberg-Schoorl ME, Ten Cate JW. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol 1984; 15, 148: 1092-1097. (Pubitemid 14136416)
21. Marietta M, Simoni L, Pedrazzi P, Facchini L, D'Amico R, Facchinetti F. Antithrombin plasma levels decrease is associated with preeclampsia worsening. Int J Lab Hematol 2009; 31: 227-232.
22. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-1050. (Pubitemid 128753793)
23. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: A risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol 2003; 189: 391-396.
24. Var A, Y?ld?r?m Y, Onur E et al. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 2003; 56: 221-224. (Pubitemid 37505854)
25. Kerkeni M, Addad F, Chauffert M et al. Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 2006; 52: 153-158.
26. Dekker GA, de Vries JIP, Doelitzsch PM et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173: 1042-1048.
27. Dizon-Townson DS, Nelson LM, Easton K,Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996; 175: 902-905. (Pubitemid 26357952)
28. Nagy B, Tóth T, Rigó JJR, Karádi I, Romics L, Papp Z. Detection of factor V Leiden in severe pre-eclamptic Hungarian women. Clin Genet 1998; 53: 478-481. (Pubitemid 28327743)
29. Rigo J Jr, Nagy B, Fintor L et al. Maternal and neonatal outcome of preeclamptic pregnancies: The potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000; 19: 163-172. (Pubitemid 30436483)
30. Morrison ER, Miedzybrodzka ZH, Campbell DM et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: Results from a large population-based study and systematic review. Thromb Haemost 2002; 87: 779-785. (Pubitemid 34516601)
31. Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004; 191: 412-424. (Pubitemid 39178692)
32. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993; 88: 1463-1469. (Pubitemid 23296892)